Page 3 - Multiple System News Today

MIDDLEBURY — Kimberly L. Seman, 57, of Middlebury, entered into heaven on Saturday, November 11, 2023, after a courageous six-year battle with Multiple System Atrophy.

Gene therapy AB-1005 being developed to locally increase glial cell line-derived neurotrophic factor (GDNF) levels in the brain for the treatment ...

MELBOURNE, Australia and SAN FRANCISCO, Nov. 16, 2023 -- Alterity Therapeutics , a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today...

Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434 November 16, 2023November 16, 2023 Alterity Therapeutics ...

BOSTON and ATLANTA, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course

BOSTON and ATLANTA, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage phar...

Jane Frances Holmes, age 72, passed away peacefully on Nov. 2, 2023, at the Pheasant Wood Center in Peterborough, surrounded by the support and love of her family and friends.

– ATH434-201 is a randomized, double-blind, placebo-controlled study in early-stage MSA – – Lead clinical development program enrolled 77 participants...

– ATH434-201 is a randomized, double-blind, placebo-controlled study in early-stage MSA – – Lead clinical development program enrolled 77 participants globally – MELBOURNE, Australia...

Inhibikase Therapeutics, Inc. (IKT) announced that risvodetinib has been granted Orphan Drug Designation by the FDA for the treatment of Multiple System Atrophy.